Health Care [ 8/12 ] | Health Care Equipment & Supplies [ 35/74 ]
NASDAQ | Common Stock
Zynex, Inc., together with its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain, and activate and exercise muscles for rehabilitative purposes with electrical stimulation.
The company offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation, and neuromuscular electrical stimulation (NMES) device that is marketed to physicians and therapists by field sales representatives; NeuroMove, an electromyography and electric stimulation technology device; InWave, an electrical stimulation product for the treatment of female urinary incontinence; E-Wave, an NMES device; and M-Wave, an NMES device.
It also supplies private labeled products, including electrodes for the delivery of electrical current to the body; and batteries for use in electrotherapy products.
In addition, the company distributes Comfortrac/Saunders for cervical traction, JetStream for hot/cold therapy, LSO Back Braces for lumbar support, braces for rehabilitation support for knee and wrist, and Dynacomp for cold compression therapy.
Further, it develops Zynex Fluid Monitoring System (CM-1500); Zynex Wireless Fluid Monitoring System (CM-1600), a noninvasive monitoring device designed to measure relative changes in fluid volume in adult patients; NiCO CO-Oximeter, a laser photoplethysmographic patient monitoring device; and HemeOx tHb Oximeter, a laser-based total hemoglobin pulse oximeter.
The company provides its products for use in pain management and control; stroke and spinal cord injury rehabilitation; and fluid monitoring and pulse oximetry monitoring.
It sells its products through direct sales force primarily in the United States.
Zynex, Inc. was founded in 1996 and is headquartered in Englewood, Colorado.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Feb 26, 25 | -0.02 Decreased by -109.52% | 0.09 Decreased by -122.22% |
| Oct 24, 24 | 0.07 Decreased by -30.00% | 0.06 Increased by +16.67% |
| Jul 25, 24 | 0.04 Decreased by -55.56% | 0.08 Decreased by -50.00% |
| Apr 30, 24 | 0.00 Decreased by -99.25% | 0.03 Decreased by -99.00% |
| Feb 29, 24 | 0.21 Increased by +5.00% | 0.17 Increased by +23.53% |
| Oct 26, 23 | 0.10 Decreased by -23.08% | 0.09 Increased by +11.11% |
| Jul 27, 23 | 0.09 Increased by +12.50% | 0.05 Increased by +80.00% |
| Apr 27, 23 | 0.04 Increased by +33.33% | 0.01 Increased by +300.00% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Dec 31, 24 | 45.97 M Decreased by -2.77% | -615.00 K Decreased by -150.62% | Decreased by -1.34% Decreased by -152.06% |
| Sep 30, 24 | 49.97 M Increased by +0.10% | 2.38 M Decreased by -33.72% | Increased by +4.77% Decreased by -33.79% |
| Jun 30, 24 | 49.88 M Increased by +10.97% | 1.22 M Decreased by -63.71% | Increased by +2.44% Decreased by -67.30% |
| Mar 31, 24 | 46.53 M Increased by +10.34% | 10.00 K Decreased by -99.36% | Increased by +0.02% Decreased by -99.42% |
| Dec 31, 23 | 47.28 M Decreased by -3.12% | 1.22 M Decreased by -83.70% | Increased by +2.57% Decreased by -83.17% |
| Sep 30, 23 | 49.91 M Increased by +20.22% | 3.59 M Decreased by -26.25% | Increased by +7.20% Decreased by -38.65% |
| Jun 30, 23 | 44.95 M Increased by +22.29% | 3.35 M Increased by +0.24% | Increased by +7.46% Decreased by -18.03% |
| Mar 31, 23 | 42.17 M Increased by +35.67% | 1.57 M Increased by +13.94% | Increased by +3.72% Decreased by -16.01% |